Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TD Vaccine System in Travelers to Asia
NCT01040325Phase 2Completed
- Sponsor
- Intercell AG
- Start
- Dec 2009
- Primary completion
- Jun 2010
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 3
01
Overview
Phase 2, randomised, double-blind trial of TD Vaccine System in traveler's diarrhea (TD) (2 arms), sponsored by Intercell AG. Primary endpoint: Incidence of cases with vaccine preventable outcome. Started Dec 2009; status: completed.
02
Drugs
TD Vaccine System
03
Conditions
traveler's diarrhea (TD)
Beyond the preview
Go deeper on NCT01040325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01040325.